{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:42:27Z","timestamp":1782164547693,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13555-019-00346-x","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T14:02:20Z","timestamp":1576936940000},"page":"179-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"10","author":[{"given":"Siriorn","family":"Sukanjanapong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin","family":"Thongtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silada","family":"Kanokrungsee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonkiat","family":"Suchonwanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-3816","authenticated-orcid":false,"given":"Kumutnart","family":"Chanprapaph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"issue":"6","key":"346_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","volume":"44","author":"C Chams-Davatchi","year":"2005","unstructured":"Chams-Davatchi C, Valikhani M, Daneshpazhooh M, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol. 2005;44(6):470\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"346_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","volume":"38","author":"S Pisanti","year":"1974","unstructured":"Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol. 1974;38(3):382\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol."},{"issue":"2","key":"346_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","volume":"132","author":"JC Bystryn","year":"1996","unstructured":"Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132(2):203\u201312.","journal-title":"Arch Dermatol."},{"issue":"6","key":"346_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40257-014-0101-9","volume":"15","author":"L Atzmony","year":"2014","unstructured":"Atzmony L, Hodak E, Gdalevich M, Rosenbaum O, Mimouni D. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis. Am J Clin Dermatol. 2014;15(6):503\u201315.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"346_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jaad.2015.04.038","volume":"73","author":"L Atzmony","year":"2015","unstructured":"Atzmony L, Hodak E, Leshem YA, et al. The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):264\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"346_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","volume":"64","author":"LK Martin","year":"2011","unstructured":"Martin LK, Werth VP, Villaneuva EV, Murrell DF. A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 2011;64(5):903\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"346_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","volume":"49","author":"D Mimouni","year":"2003","unstructured":"Mimouni D, Nousari CH, Cummins DL, Kouba DJ, David M, Anhalt GJ. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol. 2003;49(6):1059\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"346_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/1346-8138.12486","volume":"41","author":"M Amagai","year":"2014","unstructured":"Committee for Guidelines for the Management of Pemphigus Disease, Amagai M, Tanikawa A, et al. Japanese guidelines for the management of pemphigus. J Dermatol. 2014;41(6):471\u201386.","journal-title":"J Dermatol."},{"issue":"8","key":"346_CR9","first-page":"833","volume":"13","author":"R Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC, et al. S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges. 2015;13(8):833\u201344.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"5","key":"346_CR10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","volume":"177","author":"KE Harman","year":"2017","unstructured":"Harman KE, Brown D, Exton LS, et al. British Association of Dermatologists\u2019 guidelines for the management of pemphigus vulgaris 2017. Br J Dermatol. 2017;177(5):1170\u2013201.","journal-title":"Br J Dermatol"},{"issue":"3","key":"346_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","volume":"29","author":"M Hertl","year":"2015","unstructured":"Hertl M, Jedlickova H, Karpati S, et al. Pemphigus. S2 Guideline for diagnosis and treatment\u2013guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2015;29(3):405\u201314.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"346_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.021","author":"DF Murrell","year":"2018","unstructured":"Murrell DF, Pena S, Joly P, et al. Diagnosis and management of pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.jaad.2018.02.021.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"346_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","volume":"58","author":"DF Murrell","year":"2008","unstructured":"Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58(6):1043\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"346_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.det.2004.09.006","volume":"23","author":"D Kazlow Stern","year":"2005","unstructured":"Kazlow Stern D, Tripp JM, Ho VC, Lebwohl M. The use of systemic immune moderators in dermatology: an update. Dermatol Clin. 2005;23(2):259\u2013300.","journal-title":"Dermatol Clin"},{"issue":"10","key":"346_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","volume":"27","author":"C Chams-Davatchi","year":"2013","unstructured":"Chams-Davatchi C, Mortazavizadeh A, Daneshpazhooh M, et al. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2013;27(10):1285\u201392.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"3 Pt 1","key":"346_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","volume":"16","author":"W Aberer","year":"1987","unstructured":"Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol. 1987;16(3 Pt 1):527\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"346_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaad.2008.08.049","volume":"60","author":"AK Orvis","year":"2009","unstructured":"Orvis AK, Wesson SK, Breza TS Jr, Church AA, Mitchell CL, Watkins SW. Mycophenolate mofetil in dermatology. J Am Acad Dermatol. 2009;60(2):183\u201399 (quiz 200\u2013202).","journal-title":"J Am Acad Dermatol."},{"issue":"9076","key":"346_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0140-6736(05)63084-X","volume":"350","author":"AH Enk","year":"1997","unstructured":"Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet. 1997;350(9076):494.","journal-title":"Lancet"},{"issue":"1","key":"346_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archderm.135.1.54","volume":"135","author":"AH Enk","year":"1999","unstructured":"Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol. 1999;135(1):54\u20136.","journal-title":"Arch Dermatol"},{"issue":"1 Pt 1","key":"346_CR20","first-page":"23","volume":"129","author":"C Chams-Davatchi","year":"2002","unstructured":"Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, et al. Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris. Ann Dermatol Venereol. 2002;129(1 Pt 1):23\u20135.","journal-title":"Ann Dermatol Venereol"},{"issue":"8","key":"346_CR21","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/jid.2010.91","volume":"130","author":"S Beissert","year":"2010","unstructured":"Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. J Invest Dermatol. 2010;130(8):2041\u20138.","journal-title":"J Invest Dermatol."},{"issue":"7","key":"346_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1468-3083.2011.04170.x","volume":"26","author":"D Ioannides","year":"2012","unstructured":"Ioannides D, Apalla Z, Lazaridou E, Rigopoulos D. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study. J Eur Acad Dermatol Venereol. 2012;26(7):855\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"346_CR23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","volume":"142","author":"S Beissert","year":"2006","unstructured":"Beissert S, Werfel T, Frieling U, et al. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol. 2006;142(11):1447\u201354.","journal-title":"Arch Dermatol"},{"issue":"4","key":"346_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","volume":"57","author":"C Chams-Davatchi","year":"2007","unstructured":"Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"346_CR25","first-page":"626","volume":"17","author":"N Esmaili","year":"2014","unstructured":"Esmaili N, Chams-Davatchi C, Valikhani M, et al. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Arch Iran Med. 2014;17(9):626\u20138.","journal-title":"Arch Iran Med."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-00346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-019-00346-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-019-00346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T12:31:57Z","timestamp":1710419517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-019-00346-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s13555-019-00346-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,21]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}